In CML, autophagy supports leukemic stem cell survival and TKI resistance by leveraging the same mTOR, PI3K/Akt, and AMPK pathways, which are also critical in the pathogenesis of neurodegenerative and metabolic disorders. This evidence concerns the gene AKT1 and metabolic disease.